[go: up one dir, main page]

DE69129697T3 - Aus mehreren domänen bestehende hämatopoese-stimulatoren - Google Patents

Aus mehreren domänen bestehende hämatopoese-stimulatoren Download PDF

Info

Publication number
DE69129697T3
DE69129697T3 DE69129697T DE69129697T DE69129697T3 DE 69129697 T3 DE69129697 T3 DE 69129697T3 DE 69129697 T DE69129697 T DE 69129697T DE 69129697 T DE69129697 T DE 69129697T DE 69129697 T3 DE69129697 T3 DE 69129697T3
Authority
DE
Germany
Prior art keywords
hematopoese
stimulators
multiple domain
domain
hematopoietin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69129697T
Other languages
English (en)
Other versions
DE69129697D1 (de
DE69129697T2 (de
Inventor
Paul Schendel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24298530&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69129697(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genetics Institute LLC filed Critical Genetics Institute LLC
Publication of DE69129697D1 publication Critical patent/DE69129697D1/de
Application granted granted Critical
Publication of DE69129697T2 publication Critical patent/DE69129697T2/de
Publication of DE69129697T3 publication Critical patent/DE69129697T3/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69129697T 1990-08-29 1991-08-29 Aus mehreren domänen bestehende hämatopoese-stimulatoren Expired - Fee Related DE69129697T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57500390A 1990-08-29 1990-08-29
PCT/US1991/006186 WO1992004455A1 (en) 1990-08-29 1991-08-29 Multidomain hematopoiesis stimulators

Publications (3)

Publication Number Publication Date
DE69129697D1 DE69129697D1 (de) 1998-08-06
DE69129697T2 DE69129697T2 (de) 1999-01-07
DE69129697T3 true DE69129697T3 (de) 2004-01-29

Family

ID=24298530

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69129697T Expired - Fee Related DE69129697T3 (de) 1990-08-29 1991-08-29 Aus mehreren domänen bestehende hämatopoese-stimulatoren

Country Status (11)

Country Link
US (1) US5883230A (de)
EP (1) EP0546124B2 (de)
JP (1) JP3149182B2 (de)
AT (1) ATE167896T1 (de)
AU (1) AU651152B2 (de)
CA (1) CA2089553C (de)
DE (1) DE69129697T3 (de)
DK (1) DK0546124T4 (de)
ES (1) ES2118756T5 (de)
GR (1) GR3027790T3 (de)
WO (1) WO1992004455A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5718893A (en) * 1984-04-15 1998-02-17 Foster; Preston F. Use of G-CSF to reduce acute rejection
US5662896A (en) * 1988-03-21 1997-09-02 Chiron Viagene, Inc. Compositions and methods for cancer immunotherapy
CA2069746A1 (en) * 1990-09-28 1992-03-29 Jonathan I. Rosen Hybrid growth factors
US6361977B1 (en) 1992-11-24 2002-03-26 S. Christopher Bauer Methods of using multivariant IL-3 hematopoiesis fusion protein
US7091319B1 (en) 1992-11-24 2006-08-15 Bauer S Christopher IL-3 variant hematopoiesis fusion protein
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US6057133A (en) * 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
US6413509B1 (en) 1992-11-24 2002-07-02 S. Christopher Bauer Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors
US5581476A (en) * 1993-01-28 1996-12-03 Amgen Inc. Computer-based methods and articles of manufacture for preparing G-CSF analogs
US5501962A (en) * 1993-06-21 1996-03-26 G. D. Searle & Co. Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same
US5536495A (en) * 1994-04-15 1996-07-16 Foster; Preston F. Use of G-CSF to reduce acute rejection
WO1995028427A1 (en) * 1994-04-15 1995-10-26 Imclone Systems Incorporated Chimeric interleukin-3/mutein interleukin-6 lymphokine
US5582821A (en) * 1994-07-22 1996-12-10 Genetics Institute, Inc. Methods for treating bleeding disorders
JPH11500308A (ja) * 1995-02-03 1999-01-12 ジー．ディー．サール アンド カンパニー 新規ｃ−ＭＰＬリガンド
AU705064B2 (en) * 1995-04-26 1999-05-13 Kyowa Hakko Kogyo Co. Ltd. Novel polypeptides
US6540993B1 (en) 1995-06-27 2003-04-01 Wyeth Method of treating inflammatory bowel disease using a topical formulation of IL-11
US6887461B1 (en) 1998-10-26 2005-05-03 Genetics Institute, Llc Method of using IL-11 for treating mucositis
US6066318A (en) 1995-10-05 2000-05-23 G.D. Searle & Co. Multi-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factors
US6967092B1 (en) 1996-10-25 2005-11-22 Mc Kearn John P Multi-functional chimeric hematopoietic receptor agonists
US6884419B1 (en) 1996-12-23 2005-04-26 Kyowa Hakko Kogyo, Co., Ltd. hG-CSF fusion polypeptide having c-mpl activity, DNA coding for same and methods of treating anemia using same
US6242570B1 (en) * 1997-07-10 2001-06-05 Beth Israel Deaconess Medical Center Production and use of recombinant protein multimers with increased biological activity
US6187564B1 (en) 1997-07-10 2001-02-13 Beth Israel Deaconess Medical Center DNA encoding erythropoietin multimers having modified 5′ and 3′ sequences and its use to prepare EPO therapeutics
US6953777B2 (en) 1999-03-11 2005-10-11 Genetics Indtitute LLC Use of interleukin-11 to prevent immune-mediated cytotoxicity
NZ516664A (en) 1999-07-15 2003-06-30 Inst Genetics Llc Formulations and compositions for interleukin-11
JP4793971B2 (ja) * 1999-08-09 2011-10-12 メルク パテント ゲーエムベーハー 複合サイトカイン−抗体複合体
EP1731531B1 (de) * 1999-08-09 2012-05-30 Merck Patent GmbH Mehrere Zytokin-Antikörper Komplexe
US6831158B2 (en) * 2000-01-10 2004-12-14 Maxygen Holdings Ltd. G-CSF conjugates
US6555660B2 (en) * 2000-01-10 2003-04-29 Maxygen Holdings Ltd. G-CSF conjugates
US6646110B2 (en) * 2000-01-10 2003-11-11 Maxygen Holdings Ltd. G-CSF polypeptides and conjugates
WO2003006501A2 (en) 2001-07-11 2003-01-23 Maxygen Holdings, Ltd. G-csf conjugates
US6982080B2 (en) 2002-03-15 2006-01-03 Wyeth Hydroxyethyl starch—containing polypeptide compositions
DE602004031681D1 (de) 2003-07-21 2011-04-14 Transgene Sa Multifunktionelle Cytokine
US7220407B2 (en) 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
US20060153799A1 (en) 2004-11-05 2006-07-13 Northwestern University Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders
EP1888119B1 (de) 2005-06-01 2011-03-09 Maxygen, Inc. Pegylierte g-csf-polypeptide und herstellungsverfahren dafür
LT6161B (lt) * 2013-09-27 2015-06-25 Uab Profarma Granuliocitų kolonijas stimuliuojančio faktoriaus sulieti baltymai su kitais augimo faktoriais, optimaliai su kamieninių ląstelių faktoriumi, ir jų gavimo būdas

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983003971A1 (en) * 1982-05-12 1983-11-24 President And Fellows Of Harvard College Hybrid proteins
WO1985004420A1 (fr) * 1984-03-29 1985-10-10 Takeda Chemical Industries, Ltd. Nouvel adn et son utilisation
US4691009A (en) * 1984-12-26 1987-09-01 Repligen Corporation Hybrid proteins produced by an ultrahigh prokaryotic expression system
ATE78262T1 (de) * 1985-06-11 1992-08-15 Ciba Geigy Ag Hybrid-interferone.
US4935233A (en) * 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
JPS63267278A (ja) * 1986-03-14 1988-11-04 Toray Ind Inc インタ−フエロン結合体を暗号化する塩基配列
US5032395A (en) * 1986-07-14 1991-07-16 Genetics Institute, Inc. Method of inducing leukocytosis with a combination of IL-3 and GM-CSF
EP0275300B1 (de) * 1986-08-01 1996-01-03 Commonwealth Scientific And Industrial Research Organisation Rekombinanter impfstoff
EP0257406B2 (de) * 1986-08-06 1998-08-12 Ajinomoto Co., Inc. Rekombinanter B-Zell-Differenzierungsfaktor
EP0317641B1 (de) * 1987-05-29 1993-03-17 Sagami Chemical Research Center Fusionsprotein, enthaltend lymphotoxin
JPH04500508A (ja) * 1988-07-20 1992-01-30 イミュネックス・コーポレーション 非グリコシル化　ヒト　インターロイキン―３　組成物
US5217719A (en) * 1989-01-09 1993-06-08 Kao Corporation Surface-treated sodium bicarbonate particle and molded preparation thereof
US5032396A (en) * 1989-02-17 1991-07-16 Immunex Corporation IL-7 to stimulate platelet production
CA2014473A1 (en) * 1989-04-14 1990-10-14 Hong-Ji Xu Purified, highly specific antibodies against gene products including retinoblastoma and method
WO1990012877A1 (en) * 1989-04-19 1990-11-01 Cetus Corporation Multifunctional m-csf proteins and genes encoding therefor
US5166322A (en) * 1989-04-21 1992-11-24 Genetics Institute Cysteine added variants of interleukin-3 and chemical modifications thereof
JPH04501808A (ja) * 1989-07-06 1992-04-02 セラジェン・インコーポレーテッド ハイブリッド分子
US5073627A (en) * 1989-08-22 1991-12-17 Immunex Corporation Fusion proteins comprising GM-CSF and IL-3
EP0489116B1 (de) * 1989-08-22 1994-04-06 Immunex Corporation Fusionsprotein bestehend aus gm-csf und il-3
US5108910A (en) * 1989-08-22 1992-04-28 Immunex Corporation DNA sequences encoding fusion proteins comprising GM-CSF and IL-3
US5215895A (en) * 1989-11-22 1993-06-01 Genetics Institute, Inc. Dna encoding a mammalian cytokine, interleukin-11
US5238823A (en) * 1990-08-22 1993-08-24 Veterinary Infectious Disease Organization Interleukin-2-leukotoxin gene fusions and uses thereof
CA2069746A1 (en) * 1990-09-28 1992-03-29 Jonathan I. Rosen Hybrid growth factors

Also Published As

Publication number Publication date
ATE167896T1 (de) 1998-07-15
AU651152B2 (en) 1994-07-14
CA2089553C (en) 2000-06-27
DK0546124T3 (da) 1998-10-26
CA2089553A1 (en) 1992-03-01
EP0546124A1 (de) 1993-06-16
JPH06500116A (ja) 1994-01-06
DK0546124T4 (da) 2003-05-19
GR3027790T3 (en) 1998-11-30
US5883230A (en) 1999-03-16
WO1992004455A1 (en) 1992-03-19
EP0546124B2 (de) 2003-04-23
ES2118756T3 (es) 1998-10-01
JP3149182B2 (ja) 2001-03-26
ES2118756T5 (es) 2004-01-16
EP0546124B1 (de) 1998-07-01
DE69129697D1 (de) 1998-08-06
DE69129697T2 (de) 1999-01-07
AU8917491A (en) 1992-03-30

Similar Documents

Publication Publication Date Title
DE69129697T3 (de) Aus mehreren domänen bestehende hämatopoese-stimulatoren
FI895955A7 (fi) Il-2-reseptorispesifisiä "kimeerisiä" vasta-aineita
ES510011A0 (es) "un metodo de crear un microorganismo capaz de producir una proteina predeterminada por expresion".
DE3789056D1 (de) Kleine kopiervorrichtung.
CY2000009I1 (el) Συντετηγμενες πρωτεïνες με μερη ανοσοσφαιρινης, η παρασκευη και η χρηση τους
ES262584Y (es) "bisagra abatible de una sola pieza de material sintetico".
NO904632L (no) Sveiseelektrode.
FI841601A7 (fi) Prolin-derivat.
SE9301270D0 (sv) Biosensor
ES2024709B3 (es) Union de barras polioefinicas por fusion.
FI841260L (fi) Immunoglobulinkonjugater.
MX172742B (es) Compuestos de piridina 2,6 substituidos
AT382311B (de) Optisch klare, gefaerbte zahnpaste
DE3668963D1 (de) Blattfeder aus faser-kunststoff-verbundwerkstoff.
DE68901101D1 (de) Verbinden polyolefinischer teile durch schmelzen.
IT8323422A0 (it) Glicosaminoglicani modificati dotati di attivita' antitrombotica.
IT8723057A0 (it) Gasificatore di fusione.
FI842990L (fi) Plastbehaollare.
DE3475713D1 (de) 3, 3", 4" -tri-o-acylspiramycin i
DE3683974D1 (de) Kunststoffzusammensetzung aus verseiftem aethylencopolymer.
DE3483830D1 (de) Polyesteramid-schmelzkleber.
DE59003899D1 (de) Klebstoff zum Verbinden von Formteilen aus Polycarbonat-Kunststoffen.
DE3481959D1 (de) Elektrodengegenstand.
BE890372A (fr) Element d'electrolyseur bipolaire
DK288788D0 (da) Immunodiagnoseanalyser under anvendelse af kimaere antigener

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: GENETICS INSTITUTE, LLC, CAMBRIDGE, MASS., US

8366 Restricted maintained after opposition proceedings
8339 Ceased/non-payment of the annual fee